Skip to main content
Clinical Trials/DRKS00030594
DRKS00030594
Recruiting
Not Applicable

Point-of-Care PCR for the diagnosis of respiratory infections in vulnerable populations - POC-PCR_Qualitative_Study

niversitätsklinikum Heidelberg Sektion Infektions- und Tropenmedizin0 sites30 target enrollmentOctober 24, 2022

Overview

Phase
Not Applicable
Intervention
Not specified
Conditions
U07.1
Sponsor
niversitätsklinikum Heidelberg Sektion Infektions- und Tropenmedizin
Enrollment
30
Status
Recruiting
Last Updated
last year

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
October 24, 2022
End Date
TBD
Last Updated
last year
Study Type
Observational
Sex
All

Investigators

Sponsor
niversitätsklinikum Heidelberg Sektion Infektions- und Tropenmedizin

Eligibility Criteria

Inclusion Criteria

  • (1\) Patients (or, in the pediatric emergency care unit, the legal guardian), healthcare workers and decision makers aged 18 years or older
  • (2\) Visiting or working at one of the study settings (oncology ambulatory setting, dialysis unit, emergency room or paediatric emergency care) at the time of the study
  • (3\) Ability to give informed consent

Exclusion Criteria

  • (1\) Patients (or, in the pediatric emergency care unit, the legal guardian), healthcare workers and decision makers aged under 18 years
  • (2\) Not able to give informed consent

Outcomes

Primary Outcomes

Not specified

Similar Trials

Completed
Not Applicable
A controlled clinical trial investigating the impact of point of care testing for ‘atypical’ pneumonia, bordetella pertussis and viral pathogens on patient pathways, antimicrobial consumption and cost-efficiency.Rapid PCR-based diagnostic test when placed at the point of careInfections and Infestations
ISRCTN10470967King's College Hospital2,262
Recruiting
Phase 2
CRP-POCT in suspected airway infected patients in the long-term care facility
NL-OMON43304Stichting Opella50
Active, not recruiting
Phase 1
se of a respiratory multiplex PCR and procalcitonin to reduce antibiotic exposure in patients with severe confirmed COVID-19 pneumoniaSevere confirmed COVID-19 pneumoniaMedDRA version: 20.0Level: LLTClassification code 10051905Term: Coronavirus infectionSystem Organ Class: 100000004862Therapeutic area: Diseases [C] - Respiratory Tract Diseases [C08]
EUCTR2020-001324-33-FRASSISTANCE PUBLIQUE - HÔPITAUX DE PARIS (APHP)194
Completed
Not Applicable
Rapid diagnosis of respiratory infections in primary healthcare: the PrimariPOC study.common coldrespiratory tract infections1004743810024970
NL-OMON42348Academisch Medisch Centrum400
Completed
Not Applicable
The Breathe Easy study: Mask On, Mask Off (MoMo) sub study for diagnosis of respiratory illnessPneumoniaAsthmaChronic Obstructive Pulmonary Disease (COPD)Lower respiratory tract diseaseRespiratory - AsthmaRespiratory - Chronic obstructive pulmonary diseaseRespiratory - Other respiratory disorders / diseasesInfection - Other infectious diseases
ACTRN12621001086853Paul Porter221